Allergan (AGN), Mylan (MYL) Sees Short Interest Rise, Gilead (GILD) Fall in Pharma Sector - Guggenheim

September 26, 2016 5:44 PM EDT
Get Alerts ARLZ Hot Sheet
Price: $4.40 --0%

Rating Summary:
    1 Buy, 0 Hold, 0 Sell

Rating Trend: Up Up

Today's Overall Ratings:
    Up: 0 | Down: 0 | New: 0
Trade ARLZ Now!
Join SI Premium – FREE

News and research before you hear about it on CNBC and others. Claim your 2-week free trial to StreetInsider Premium here.

Guggenheim analyst Louise Chen provided a quick analysis of the latest short interest data (09/15/16) in the pharma sector.

Chen notes the largest increase in short interest is Aralez (NASDAQ: ARLZ) at +26.3%, followed closely by Allergan (NYSE: AGN) at +24.7%.

The company with the largest decrease in short interest is Gilead (NASDAQ: GILD) at -10.4%.

Other Notables:

Mylan, Inc. (NYSE: MYL) short interest up 17.7% to 25,313,358 shares.

Valeant Pharmaceuticals Inc. (NYSE: VRX) short interest up 1.2% to 26,396,945.

Bristol Myers Squibb (NYSE: BMY) short interest up 13.1% to 13,960,166 shares

Endo Pharmaceuticals (NASDAQ: ENDP) short interest up 16.7% to 16,003,377 shares.

Celgene (NASDAQ: CELG) short interest up 18.7% to 6,953,530 shares.

Serious News for Serious Traders! Try Premium Free!

You May Also Be Interested In

Related Categories

Analyst Comments, Short Sales, Trader Talk

Related Entities

Louise Chen, Guggenheim

Add Your Comment